State-of-the-art short-read transcriptome sequencing methods employ unique molecular identifier (UMI) to accurately classify and count mRNA transcripts. A fundamental limitation of UMI-based short-read transcriptome sequencing is that each read typically covers a small fraction of the transcript sequence.
Introduction
Whole transcriptome analysis has a profound impact in understanding the relationship between gene expressions, isoform sequences, and the complex phenotypes of cellular developments and diseases. With the advance in Next Generation Sequencing, many different protocols and toolsets have been developed to provide more insights into whole transcriptome at the sequence level. Current transcriptome sequencing techniques include 3' short read sequencing of polyadenylated RNA while measuring transcript abundance, reference-based short read transcript sequence assembly, and full-length transcript sequencing using longread sequencers. While current transcriptome sequencing methods have made large strides in the transcriptome field, it remains difficult and cost-prohibitive to detect and discover new alternative splicing events, which have been implicated in many cancers and hereditary diseases.
We have developed a method for reconstructing long read sequences using Illumina's short-read sequencers. The sample prep workflow includes reverse transcription, cDNA amplification, barcode distribution, and Illumina adaptor attachment and amplification. During reverse transcription, each complementary DNA (cDNA) is tagged with sample barcode and a unique molecular identifier (UMI). The UMI, or barcode, is used to differentiate between PCR duplicates and transcripts of identical sequences, as well as providing relative abundance of the transcripts without the interference of PCR amplification bias.
Following cDNA amplification, the barcodes on each cDNA is distributed across the length of the cDNA molecule, before being converted into Illumina sequencing libraries completed with handles suitable for cluster amplification and sequencing on an Illumina sequencer. With a simple modification of the sample prep workflow, the short-read sequencing read coverage can either be used for reconstructing long RNA transcripts ("phasing" workflow) or for counting transcripts with a sparse coverage within each transcript ("counting" workflow). The choice of workflow offers flexibility for when transcript discovery and isoform identification are the focus of the study or when transcriptome abundance measurement is desired. In the data presented below, the transcriptomes of total RNA extracted from human brain, liver, and blood are surveyed at different sequencing depth per transcript. The impact of RNA sample integrity as well as sequencing depth on the reconstructed long reads are examined. Sequence annotation and splice junction analysis are conducted using SQANTI, an analysis pipeline for characterizing long read transcript sequences.
Results and discussion
Input RNA Analysis
The RNA integrity of the total RNA from human brain, liver, and blood were assessed using Agilent Bioanalyzer RNA 6000 Nano kit coupled with the Eukaryote Total RNA analysis workflow. Figure 1 shows the electropherograms of different human total RNA samples. The highest RIN score of the total RNA sample is from human liver total RNA at 7.4, followed by the human brain total RNA with a RIN score of 6.1, followed by the human blood total RNA with a RIN score of 2.4. The three human total RNA samples cover a wide range of RIN scores at realistic sample integrities that one might encounter with tissue extracted RNA and serve as good model samples for method validation with the LoopSeq Transcriptome kit. 
Relationship between Sample Complexity and Sequencing Depth
For de novo assembly of RNA transcripts, it is important to consider the sequencing fold coverage one needs to sufficiently cover the starting molecule, or "coverage per transcript" as referred to below. When considering the sequencing need on a per sample level, one also needs to consider the number of molecules the sequencing read coverage is going towards. Different total RNA samples can contain different levels of mRNA molecules, which in terms impacts the number of uniquely barcoded cDNA molecules that are made. This is referred to as the "sample complexity" of the tagged sample, or the At the extreme ends, when the short-read coverage is 20 reads or lower per transcript, e.g. with the counting workflow of the LoopSeq Transcriptome kit, the data set is best used for counting transcripts.
With the sparse coverage per transcript, one can still obtain information on the gene functions of the transcripts but not necessarily the transcript sequence in its entirely. On the other hand, when the shortread coverage is 200 reads or more per transcript, e.g. with the phasing workflow of the LoopSeq Transcriptome kit, the data set can be used to reconstruct transcript sequences. Depending on the length of the starting RNA molecules, that can either lead to a full-length reconstruction with short RNA molecules or a partial reconstruction with long RNA molecules. Additional short read coverage contributes more The fraction of reference coverage from two different sequence coverages of the human brain sample.
sequence information disproportionally towards longer starting RNA molecules, leading to longer contig reconstruction and full length contigs.
Impact of Sample Integrity and Contig Length
During reverse transcription and molecular barcode tagging, the RNA molecules are copied into complementary DNA (cDNA) for downstream sample preps. Only full-length RNA molecules can be reverse transcribed into cDNA and amplified. When the starting RNA sample is highly degraded, the length distribution of the reconstructed contigs are generally short because the cDNAs that were tagged and amplified were short. An example of the impact on contig length due to the RNA sample integrity is shown in Figure 3 . Between the human brain sample (RIN score of 6.1) and the human liver sample (RIN score of 7.4), the contig length histogram as well as the fraction of reference coverage are comparable. However, for the human blood sample, with a RIN score of 2.1 indicating significant RNA degradation, the 
Long-read Transcript Analysis using SQANTI
To analyze the single-molecule long reads, the contigs of the human brain and the human liver samples at high coverage per transcript were taken through the SQANTI pipeline 1 for transcript quality assessment and transcript classification. By comparing the splice junctions observed in the contig sequences against the Human RefSeq database and the human reference genome GRCh37, the quality of the reconstructed contigs were assessed. The annotated contigs, or isoforms, are summarized in Table 1 . SQANTI analysis annotates the contigs using the following criteria:
• Full Splice Match (FSM): the input contigs match the reference transcripts at all splice junctions for human brain and human liver RNA respectively. Genic introns, which are contigs that map entirely within the boundaries of an annotated intron, account for the majority of the remaining reconstructed contigs. Note that the consideration of contig annotation percentage calculation excludes contigs that are mapped to the complementary strand of an annotated gene. This is because during de novo contig assembly, the LoopSeq pipeline does not differentiate between the sense and the antisense strand of the reference transcript, and the resulting contigs can be of either strand, though the cDNA molecule generated contains the antisense sequence. However, many of the analysis done by SQANTI omits consideration of the antisense transcripts, which means that some of the statistics may be underreporting that of the LoopSeq long read dataset. In addition, the LoopSeq reconstructed contigs may or may not be full length transcripts because they are highly dependent on the sequencing depth of the sample or the To dissect the novel isoforms further, SQANTI analysis also examines the splice junctions of the contigs.
Two categories of splice junctions are defined using the dinucleotides at the beginning and the end of the introns that are spliced:
• Canonical: GT-AG, GC-AG, AT-AC dinucleotide pairs. This arises from the observation that 99.9% of all human introns are composed of these 3 dinucleotide pairs, with GT-AG being the most common dinucleotide pair in the human genome.
• Non-canonical: all other possible combination not include as canonical dinucleotide pairs.
Examining the splice junctions in the reconstructed contigs, canonical splice junctions from previously annotated genes account for 93.8% and 90.6% of the observed splice junctions with the human brain and human liver sample respectively, while non-canonical splice junctions from previously annotated genes account for less than 0.1% of the splice junctions. the downstream exon boundary. As shown in Figure 4 , the RT switching event categorized by the presence of repeat sequence is found at roughly 6 -8% of the splice junctions in novel transcripts (canonical and non-canonical), while it is found <1% of the splice junctions in known transcripts. 
Materials and Methods

Materials
Data analysis
The fastq output files from sequencing was used as the input into the Loop Genomics data analysis pipeline for sample demultiplexing and long read reconstruction. Briefly, the fastq files were verified and demultiplexed using the sample barcodes. The short reads from each sample were then split into chunks using molecular barcodes, before being reconstructed into single-molecule long reads using de novo assembly algorithm. The output long reads, or contigs, were reference mapped to the human RefSeq for sequence identification and for generating sample prep statistics. SQANTI analysis was conducted on the long read contig outputs from the Loop Genomics pipeline using human RefSeq as transcriptome reference and GRCh37 as the genome reference for sequence alignment.
